What are the primary causes of psoriasis in the USA?

What are the primary causes of psoriasis in the USA?

1. Genetic Predisposition

• Family history: Psoriasis often runs in families, and certain genetic markers (like HLA-Cw6) are associated with a higher risk of developing the condition.
• About 30% of people with psoriasis have a close relative with the disease.

2. Immune System Dysfunction

• Psoriasis is caused by an overactive immune system, where T-cells mistakenly attack healthy skin cells, leading to inflammation and rapid skin cell turnover.

3. Environmental Triggers

• Stress: Emotional or psychological stress is a common trigger.
• Infections: Strep throat is strongly linked to guttate psoriasis. Other infections, like HIV, can also worsen symptoms.
• Cold, dry weather: Harsh weather conditions can dry out the skin and exacerbate flare-ups.

4. Lifestyle Factors

• Obesity: Excess weight can worsen psoriasis, particularly in skin folds.
• Smoking: Tobacco use is a significant risk factor for psoriasis and can make symptoms worse.
• Alcohol consumption: Excessive drinking may trigger or exacerbate psoriasis.

5. Medications

• Beta-blockers
• Lithium
• Antimalarial drugs
• Nonsteroidal anti-inflammatory drugs (NSAIDs)

6. Hormonal Changes

• Hormonal shifts, such as those during puberty, pregnancy, or menopause, can influence psoriasis severity.

7. Skin Injuries (Koebner Phenomenon)

• Trauma to the skin, such as cuts, scrapes, sunburns, or even tattoos, can trigger psoriasis lesions in the injured area.

8. Other Health Conditions

• Metabolic syndrome: Conditions like obesity, hypertension, and type 2 diabetes are linked to psoriasis.
• Sleep disorders: Sleep deprivation and conditions like sleep apnea may exacerbate psoriasis symptoms.

1. Family History and Heredity

• Psoriasis often runs in families, indicating a strong genetic link.
• Risk by relation:
  • If one parent has psoriasis, the risk is approximately 10-15%.
  • If both parents have psoriasis, the risk increases to about 50%.
• Siblings of affected individuals are also at a higher risk compared to the general population.

2. Key Genetic Associations

• Psoriasis is a polygenic disorder, meaning multiple genes contribute to its development. Some key genes include:
  • HLA-Cw6: This gene variant, part of the human leukocyte antigen (HLA) complex, is the strongest genetic risk factor, especially for early-onset psoriasis and guttate psoriasis.
  • IL23R and IL12B: These genes regulate interleukin signaling pathways, which influence inflammation and immune responses.
  • TNFAIP3 and TNIP1: Involved in controlling inflammation and immune activation.
  • CARD14: Variants in this gene are linked to plaque psoriasis and pustular psoriasis.

3. Immune System Dysfunction

• Many of the genetic variants associated with psoriasis are involved in regulating the immune system, particularly the activity of T-cells (a type of white blood cell).
  • In psoriasis, genetic mutations cause T-cells to attack healthy skin cells mistakenly, leading to inflammation and the rapid overproduction of skin cells.

4. Gene-Environment Interaction

• Genetics alone is not sufficient to cause psoriasis. Environmental factors often trigger the disease in people with a genetic predisposition.
  • Common triggers include stress, infections (like strep throat), skin injuries, and certain medications.
  • For example, individuals with the HLA-Cw6 gene may develop guttate psoriasis after a strep infection.

5. Variability Across Ethnic Groups

• The prevalence of psoriasis and the genetic factors associated with it vary by ethnicity:
  • Psoriasis is more common in individuals of European descent.
  • The specific genetic markers, like HLA-Cw6, are more frequent in populations with a higher incidence of psoriasis.

6. Insights from Genetic Studies

• Genome-wide association studies (GWAS) have identified over 60 genetic loci linked to psoriasis.
• These findings have provided a better understanding of the disease mechanisms and have guided the development of targeted therapies, such as biologics that inhibit specific immune pathways (e.g., TNF-alpha, IL-17, IL-23).

7. Personalized Medicine

• Genetic research helps predict individual responses to treatment:
  • People with specific genetic markers may respond better to certain biologics or therapies.
  • This paves the way for more personalized, effective treatment plans.

This article is for general educational purposes and does not replace professional medical advice. Talk to your healthcare professional about diagnosis and treatment.